Related references
Note: Only part of the references are listed.Matrix metalloproteinase-12 cleaved fragment of titin as a predictor of functional capacity in patients with heart failure and preserved ejection fraction
Patricia Palau et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2021)
SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload
Hannah J. Riley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial
Corrado De Marco et al.
ESC HEART FAILURE (2021)
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis
Matthew W. Segar et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Association of Longitudinal Trajectory of Albuminuria in Young Adulthood With Myocardial Structure and Function in Later Life: Coronary Artery Risk Development in Young Adults (CARDIA) Study
Ravi B. Patel et al.
JAMA CARDIOLOGY (2020)
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Asa K. Hedman et al.
HEART (2020)
Reappraising the role of inflammation in heart failure
Luigi Adamo et al.
NATURE REVIEWS CARDIOLOGY (2020)
Research Priorities for Heart Failure With Preserved Ejection Fraction National Heart, Lung, and Blood Institute Working Group Summary
Sanjiv J. Shah et al.
CIRCULATION (2020)
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction Detailed Phenotypes, Prognosis, and Response to Spironolactone
Jordana B. Cohen et al.
JACC-HEART FAILURE (2020)
Inflammation in Heart Failure JACC State-of-the-Art Review
Sean P. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Adhesion Molecules in Early Adulthood Predict Heart Failure With Preserved Ejection Fraction at Older Age
Walter J. Paulus
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life
Ravi B. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Natriuretic Peptides as Inclusion Criteria in Clinical Trials A JACC: Heart Failure Position Paper
Nasrien E. Ibrahim et al.
JACC-HEART FAILURE (2020)
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Election Fraction
Jonathan W. Cunningham et al.
JACC-HEART FAILURE (2020)
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2020)
Pressure overload generates a cardiac-specific profile of inflammatory mediators
Matthew O'Brien et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
Michael S. Sabbah et al.
CIRCULATION-HEART FAILURE (2020)
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
Alexander J. M. Brown et al.
EUROPEAN HEART JOURNAL (2020)
Differential Associations of Chronic Inflammatory Diseases with Incident Heart Failure
Sameer Prasada et al.
JACC-HEART FAILURE (2020)
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis
Virginia S. Hahn et al.
JACC-HEART FAILURE (2020)
The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart
Lydia E. Matesic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
Jonathan W. Cunningham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction Results From the PROMIS-HFpEF Study
Sandra Sanders-van Wijk et al.
CIRCULATION (2020)
Change the Laminin, Change the Cardiomyocyte: Improve Untreatable Heart Failure
Camila Hochman-Mendez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial
Paul W. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction The CAPACITY HFpEF Randomized Clinical Trial
James E. Udelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Regulation of titin-based cardiac stiffness by unfolded domain oxidation (UnDOx)
Christine M. Loescher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study
Milad Baniaamam et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Circulating Vascular Cell Adhesion Molecule-1 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA)
Ravi B. Patel et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri T. Kato et al.
CIRCULATION (2019)
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program
Gemma A. Figtree et al.
CIRCULATION (2019)
Nitrosative stress drives heart failure with preserved ejection fraction
Gabriele G. Schiattarella et al.
NATURE (2019)
PDE1 inhibition facilitates proteasomal degradation of misfolded proteins and protects against cardiac proteinopathy
Hanming Zhang et al.
SCIENCE ADVANCES (2019)
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease The EMPA-HEART CardioLink-6 Randomized Clinical Trial
Subodh Verma et al.
CIRCULATION (2019)
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial
Stefan D. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction
Dan Tong et al.
CIRCULATION (2019)
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Brendan M. Everett et al.
CIRCULATION (2019)
Associations Between the Cyclic Guanosine Monophosphate Pathway and Cardiovascular Risk Factors: MESA
Wendy Ying et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
Gaia Calamera et al.
COMMUNICATIONS BIOLOGY (2019)
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
Kim A. Connelly et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
Rio P. Juni et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
Bo Bai et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Inflammation and cardio-renal interactions in heart failure: a potential role for interleukin-6
Jennifer S. Hanberg et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis
Lindsay T. McDonald et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Titin Gene and Protein Functions in Passive and Active Muscle
Wolfgang A. Linke
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load
Andre M. Leite-Moreira et al.
CARDIOVASCULAR RESEARCH (2018)
Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1
Anna-Eliane Hopf et al.
CIRCULATION RESEARCH (2018)
Softening the Stressed Giant Titin in Diabetes Mellitus
Mei Methawasin et al.
CIRCULATION RESEARCH (2018)
Cardiac macrophages promote diastolic dysfunction
Maarten Hulsmans et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study An Echocardiographic Study Over 3 Decades
Ramachandran S. Vasan et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Rudolf A. de Boer et al.
JAMA CARDIOLOGY (2018)
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2018)
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
Sanjiv J. Shah et al.
EUROPEAN HEART JOURNAL (2018)
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
Hilary M. DuBrock et al.
PLOS ONE (2018)
Empagliflozin directly improves diastolic function in human heart failure
Steffen Pabel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction The INDIE-HFpEF Randomized Clinical Trial
Barry A. Borlaug et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network
Marat Fudim et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
Antonius Baartscheer et al.
DIABETOLOGIA (2017)
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Burkert Pieske et al.
EUROPEAN HEART JOURNAL (2017)
Titin isoforms are increasingly protected against oxidative modifications in developing rat cardiomyocytes
Beta Bodi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure
Angla Mantel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
α-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes
Constantijn Franssen et al.
CIRCULATION-HEART FAILURE (2017)
Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium
Hiroe Toba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model (TtnIAjxn)
Mathew Bull et al.
CIRCULATION RESEARCH (2016)
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Constantijn Franssen et al.
JACC-HEART FAILURE (2016)
Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization
Hiroe Toba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction - A Report From the CHART-2 Study -
Kotaro Nochioka et al.
CIRCULATION JOURNAL (2015)
HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis
Ludivine Renaud et al.
CIRCULATION-HEART FAILURE (2015)
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction
Sandra Sanders-van Wijk et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
Margaret M. Redfield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
Benjamin Wallace Van Tassell et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis
Konstantinos Savvatis et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging
Hitomi Kobayashi et al.
JOURNAL OF RHEUMATOLOGY (2014)
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
Frank P. Brouwers et al.
EUROPEAN HEART JOURNAL (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing
Catalin F. Baicu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Effects of the absence of procollagen C-endopeptidase enhancer-2 on myocardial collagen accumulation in chronic pressure overload
Catalin F. Baicu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction
Rajalakshmi Santhanakrishnan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Myocardial remodeling with aortic stenosis and after aortic valve replacement: Mechanisms and future prognostic implications
William M. Yarbrough et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In Vivo
Kalkidan Bishu et al.
CIRCULATION (2011)
Inflammatory Markers and Incident Heart Failure Risk in Older Adults The Health ABC (Health, Aging, and Body Composition) Study
Andreas Kalogeropoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy
Michael H. Radke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Share Paper
